Milda Maciuleviciute
About Milda Maciuleviciute
Milda Maciuleviciute is a Clinical Content Developer with a background in healthcare data coordination. She has studied at multiple institutions, including Ohio University and the University of Pittsburgh, and has worked at CoverMyMeds since 2014.
Work at CoverMyMeds
Milda Maciuleviciute has been employed at CoverMyMeds since 2014, currently holding the position of Clinical Content Developer. In this role, she focuses on developing clinical content that supports healthcare providers and patients in accessing medications. Prior to her current position, she worked as a Healthcare Data Coordinator at CoverMyMeds from 2012 to 2014. Her experience in both roles contributes to her understanding of healthcare data and clinical processes.
Education and Expertise
Milda Maciuleviciute has a diverse educational background in healthcare and medicine. She studied at Ohio Wesleyan University from 2005 to 2007, followed by a two-year program at Ohio University Heritage College of Osteopathic Medicine, where she earned her bachelor's degree from 2007 to 2009. She further expanded her knowledge at the University of Pittsburgh from 2009 to 2011. Additionally, she briefly attended Universidad de Salamanca in 2007.
Background
Milda Maciuleviciute has a background in healthcare, with a focus on clinical content development and data coordination. Her career at CoverMyMeds began in 2012, and she has since gained extensive experience in the healthcare technology sector. Her academic pursuits in various institutions have equipped her with a solid foundation in medicine and healthcare practices.
Professional Experience
Milda Maciuleviciute's professional experience spans over a decade in the healthcare industry. She began her career at CoverMyMeds as a Healthcare Data Coordinator, where she worked for two years before transitioning to her current role as a Clinical Content Developer. Her ongoing tenure at CoverMyMeds reflects her commitment to improving healthcare access and efficiency through technology.